Skip to main content
Equibles

Linhai Zhao

Analyst

Goldman Sachs

Equibles does not estimate personal net worth.

About Linhai Zhao

Linhai Zhao is recorded as Analyst at Goldman Sachs. Linhai Zhao has spoken on 1 earnings call across 1 company, most recently for Legend Biotech Corp on March 10, 2026. The companies whose calls Linhai Zhao spoke on are classified in the Healthcare sector.

Linhai Zhao on recent calls

“You mentioned about the current CAR T penetrations less than 10% in the fifth line and also less than 5% in second to fourth line multiple myeloma. Just curious, what would be your practical target?”
Analyst — Goldman Sachs, ​Legend Biotech Reports Fourth Quarter 2025 Financial Results ·

Affiliation history

  • Goldman Sachs

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity